TrialDiabetes2026

Phase I Clinical Trial of Islet Antigen-Specific Plasmid Coexpressing Tolerogenic Proteins Demonstrates Safety in Adults With Type 1 Diabetes.

Carla J Greenbaum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.